AU5567501A - Disulfide derivatives useful for treating allergic diseases - Google Patents

Disulfide derivatives useful for treating allergic diseases

Info

Publication number
AU5567501A
AU5567501A AU5567501A AU5567501A AU5567501A AU 5567501 A AU5567501 A AU 5567501A AU 5567501 A AU5567501 A AU 5567501A AU 5567501 A AU5567501 A AU 5567501A AU 5567501 A AU5567501 A AU 5567501A
Authority
AU
Australia
Prior art keywords
allergic diseases
derivatives useful
treating allergic
disulfide derivatives
disulfide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU5567501A
Other languages
English (en)
Inventor
Zixia Feng
Mark R Hellberg
Steven T Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Alcon Universal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Universal Ltd filed Critical Alcon Universal Ltd
Publication of AU5567501A publication Critical patent/AU5567501A/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • C07C323/44—X or Y being nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU5567501A 2000-05-19 2001-04-25 Disulfide derivatives useful for treating allergic diseases Pending AU5567501A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20582700P 2000-05-19 2000-05-19
PCT/US2001/013331 WO2001090060A1 (en) 2000-05-19 2001-04-25 Disulfide derivatives useful for treating allergic diseases

Publications (1)

Publication Number Publication Date
AU5567501A true AU5567501A (en) 2001-12-03

Family

ID=22763799

Family Applications (2)

Application Number Title Priority Date Filing Date
AU5567501A Pending AU5567501A (en) 2000-05-19 2001-04-25 Disulfide derivatives useful for treating allergic diseases
AU2001255675A Ceased AU2001255675B2 (en) 2000-05-19 2001-04-25 Disulfide derivatives useful for treating allergic diseases

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001255675A Ceased AU2001255675B2 (en) 2000-05-19 2001-04-25 Disulfide derivatives useful for treating allergic diseases

Country Status (19)

Country Link
US (3) US6492552B2 (enExample)
EP (1) EP1282599B1 (enExample)
JP (1) JP2003534318A (enExample)
KR (1) KR20030007589A (enExample)
CN (2) CN1241912C (enExample)
AR (1) AR028566A1 (enExample)
AT (1) ATE330938T1 (enExample)
AU (2) AU5567501A (enExample)
BR (1) BR0110943A (enExample)
CA (1) CA2407964A1 (enExample)
CY (1) CY1105164T1 (enExample)
DE (1) DE60120961T2 (enExample)
DK (1) DK1282599T3 (enExample)
ES (1) ES2261402T3 (enExample)
MX (1) MXPA02011481A (enExample)
PL (1) PL365457A1 (enExample)
PT (1) PT1282599E (enExample)
WO (1) WO2001090060A1 (enExample)
ZA (1) ZA200208840B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1173697C (zh) * 2000-05-19 2004-11-03 爱尔康公司 用于治疗过敏性疾病的苯胺二硫化物衍生物
WO2004039765A1 (en) * 2002-10-31 2004-05-13 Amersham Biosciences Ab Use of urea variants as affinity ligands
KR20070024618A (ko) * 2004-06-28 2007-03-02 알콘, 인코퍼레이티드 알레르기성 질환 치료용 국소 제제
ATE421547T1 (de) * 2004-12-22 2009-02-15 California Inst Of Techn Abbaubare polymere und herstellungsverfahren dafür
US20130011378A1 (en) 2011-06-17 2013-01-10 Tzung-Horng Yang Stable formulations of a hyaluronan-degrading enzyme
NZ618331A (en) * 2011-06-17 2016-04-29 Halozyme Inc Stable formulations of a hyaluronan-degrading enzyme
FR3057264B1 (fr) * 2016-10-12 2020-05-29 Arkema France Composes porteurs de groupes associatifs azotes
CN108586299B (zh) * 2018-06-06 2020-06-16 北京化工大学 一种可引发、聚合及降低体积收缩的芳香二硫化合物的制备方法及用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1232787A (enExample) 1967-08-08 1971-05-19
US3663616A (en) 1969-10-13 1972-05-16 Sherwin Williams Co Bis(2-carbamylphenyl)disulfides
EP0062827B1 (en) 1978-06-16 1986-07-23 Kyowa Hakko Kogyo Co., Ltd Novel benzamide derivatives
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
GB9020933D0 (en) 1990-09-26 1990-11-07 Ici Plc Compound,preparation and use
US5859017A (en) 1994-04-01 1999-01-12 Cell Therapeutics, Inc. Method for inhibiting mast cell and basophil activation
US5734081A (en) 1994-08-05 1998-03-31 Warner-Lambert Company Arylthio compounds
US5463122A (en) 1994-08-05 1995-10-31 Warner-Lambert Company Arylthio compounds
US6001555A (en) 1994-09-23 1999-12-14 The United States Of America As Represented By The Department Of Health And Human Services Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein
JPH095926A (ja) * 1995-04-18 1997-01-10 Fuji Photo Film Co Ltd 熱現像感光材料
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
WO1997038693A1 (en) 1996-04-18 1997-10-23 Alcon Laboratories, Inc. Calcium channel blockers as human conjunctival mast cell degranulation inhibitors for treating ocular allergic conditions
JP2894445B2 (ja) 1997-02-12 1999-05-24 日本たばこ産業株式会社 Ｃｅｔｐ活性阻害剤として有効な化合物
JP3940201B2 (ja) 1997-05-20 2007-07-04 大塚製薬株式会社 ３，３’−ジチオジベンゾヒドロキサム酸

Also Published As

Publication number Publication date
CN1175807C (zh) 2004-11-17
US6500864B1 (en) 2002-12-31
US20020193634A1 (en) 2002-12-19
HK1050185A1 (en) 2003-06-13
CN1241912C (zh) 2006-02-15
PT1282599E (pt) 2006-08-31
ZA200208840B (en) 2003-12-02
AU2001255675B2 (en) 2005-04-14
AR028566A1 (es) 2003-05-14
ATE330938T1 (de) 2006-07-15
PL365457A1 (en) 2005-01-10
DE60120961T2 (de) 2006-11-16
WO2001090060A1 (en) 2001-11-29
CN1429209A (zh) 2003-07-09
KR20030007589A (ko) 2003-01-23
US20020058709A1 (en) 2002-05-16
ES2261402T3 (es) 2006-11-16
US20020193633A1 (en) 2002-12-19
CN1616422A (zh) 2005-05-18
DE60120961D1 (de) 2006-08-03
EP1282599A1 (en) 2003-02-12
MXPA02011481A (es) 2003-06-06
BR0110943A (pt) 2004-01-06
US6492552B2 (en) 2002-12-10
DK1282599T3 (da) 2006-07-31
US6506802B2 (en) 2003-01-14
JP2003534318A (ja) 2003-11-18
EP1282599B1 (en) 2006-06-21
CA2407964A1 (en) 2001-11-29
CY1105164T1 (el) 2010-03-03

Similar Documents

Publication Publication Date Title
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
IL150742A0 (en) Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease
IL173439A0 (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
IL209352A0 (en) 4-tetrazolyl-4phenylpiperidine derivatives for treating pain
AU2003259249A1 (en) Pyridazinylpiperazine derivatives for treating pain
NO20040198L (no) Dolastatin 10 derivater
AU2001288271A1 (en) Methods for treating inflammatory diseases
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
PL358481A1 (en) 6-hydroxy-indazole derivatives for treating glaucoma
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU5567501A (en) Disulfide derivatives useful for treating allergic diseases
AU2001241162A1 (en) Remedies for allergic diseases
AU5722701A (en) Aniline disulfide derivatives for treating allergic diseases
ATE250611T1 (de) Pyranoindole zur glaukombehandlung
EP1435970A4 (en) METHOD OF TREATING SKIN WITH DIPHOSPHONATE DERIVATIVES
PT1698338E (pt) S-metil-di-hidro-ziprasidona para o tratamento de distúrbios psiquiátricos
AU5380701A (en) Compositions containing a benzamide disulfide derivative for treating allergic diseases
AU2002342188A8 (en) Methods and compositions for treating flavivirus-mediated disease
EE200300379A (et) Alküülfenüüliminoimidasolidiini derivaadid uriinipidamatuse ravimiseks
AU2002353915A1 (en) Methods and compositions for treating rotavirus-mediated disease
EP1426060A4 (en) REMEDIES FOR ALLERGIC DISEASES
EE200300177A (et) m-aminofenüüliminoimidasolidiinderivaadid uriinipidamatuse raviks
AU3263301A (en) Method for treating allergic diseases
HK1057753A (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases